Daiwa Securities Group Inc. Intercept Pharmaceuticals, Inc. Transaction History

Daiwa Securities Group Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$11.61 - $16.11 $1,219 - $1,691	105 Added 169.35%	167 $2,000
Q4 2020 Feb 04, 2021	SELL	$24.48 - $42.47 $3,011 - $5,223	-123 Reduced 66.49%	62 $2,000
Q4 2019 Jan 31, 2020	SELL	$57.36 - $124.1 $1,147 - $2,482	-20 Reduced 9.76%	185 $23,000
Q2 2019 Jul 24, 2019	BUY	$77.77 - $120.68 $1,244 - $1,930	16 Added 8.47%	205 $16,000
Q1 2019 Apr 26, 2019	SELL	$91.83 - $120.68 $1,836 - $2,413	-20 Reduced 9.57%	189 $21,000
Q4 2018 Feb 05, 2019	BUY	$85.79 - $126.46 $6,005 - $8,852	70 Added 50.36%	209 $21,000
Q1 2018 May 02, 2018	BUY	$52.72 - $67.25 $7,328 - $9,347	139 New	139 $9,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.